Related references
Note: Only part of the references are listed.Synthetic high-density lipoproteins delivering liver X receptor agonist prevent atherogenesis by enhancing reverse cholesterol transport
Wenmin Yuan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Prophylactic and therapeutic effects of different doses of vitamin C on high-fat-diet-induced non-alcoholic fatty liver disease in mice
Qingmin Zeng et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Nitrergic signaling modulation by ascorbic acid treatment is responsible for anxiolysis in mouse model of anxiety
Vaibhav Walia et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Dietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver disease
Dana Ivancovsky-Wajcman et al.
DIGESTIVE AND LIVER DISEASE (2019)
Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice
Hyunghee Lee et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD
Daniel Garcia et al.
CELL REPORTS (2019)
LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
Xue-Yang Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Emily A. Day et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes
Chinnadurai Veeramani et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Anthocyanins and phenolic acids from a wild blueberry (Vaccinium angustifolium) powder counteract lipid accumulation in THP-1-derived macrophages
Cristian Del Bo' et al.
EUROPEAN JOURNAL OF NUTRITION (2016)
Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway
Wenquan Hu et al.
HEPATOLOGY (2016)
Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-DEPENDENT MECHANISM
Miao Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Inhibition of ERK1/2 and Activation of LXR Synergistically Reduce Atherosclerotic Lesions in ApoE-Deficient Mice
Yuanli Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Progress in the development of fatty acid synthase inhibitors as anticancer targets
Genevieve E. Mullen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
High-Fat Diet Alters Serum Fatty Acid Profiles in Obesity Prone Rats: Implications for In Vitro Studies
Tzu-Wen Liu et al.
LIPIDS (2015)
Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice
Arjunan Sundaresan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Vitamin C exerts beneficial hepatoprotection against Concanavalin A-induced immunological hepatic injury in mice through inhibition of NF-κB signal pathway
Tao Liang et al.
FOOD & FUNCTION (2014)
A Liver-Selective LXR Inverse Agonist That Suppresses Hepatic Steatosis
Kristine Griffett et al.
ACS CHEMICAL BIOLOGY (2013)
The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease
Simon Ducheix et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Peroxisome Proliferator-activated Receptor γ Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression
Yajun Duan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Association between vitamin C deficiency and dialysis modalities
Kunying Zhang et al.
NEPHROLOGY (2012)
Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials
Marc P. McRae
JOURNAL OF CHIROPRACTIC MEDICINE (2008)
Hypertriglyceridemia
John D. Brunzell
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Hypertriglyceridemia: its etiology, effects and treatment
George Yuan et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin
F Andreelli et al.
ENDOCRINOLOGY (2006)
Genetic determinants of the metabolic syndrome
Rebecca L. Pollex et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)
Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver
M Foretz et al.
DIABETES (2005)
Nonalcoholic fatty liver disease
LA Adams et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Metabolic syndrome: Definition, pathophysiology, and mechanisms
PJ Miranda et al.
AMERICAN HEART JOURNAL (2005)
Coronary artery disease risk in familial combined - Hyperlipidemia and familial hypertriglyceridemia - A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study
PN Hopkins et al.
CIRCULATION (2003)
Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis
VG Athyros et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid
Y Nakata et al.
CIRCULATION (2002)
Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c
GS Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
